Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Minnesota removes race as factor in rationing COVID-19 antibodies | Star Tribune

Minnesota has removed race as a preferential factor for determining which COVID-19 patients should receive scarce monoclonal antibodies …Read MoreMinnesota has removed race as a preferential factor for determining which COVID-19 patients should receive scarce monoclonal antibodies …

Scroll to Top